The legacy success of sildenafil has undeniably transformed the pharmaceutical landscape. However, investing in companies heavily focused on copycat drugs and the diminishing patent exclusivity surrounding https://socials360.com/story12011526/the-blue-pill-and-pharmaceutical-companies-a-uncertain-opportunity